IL-17A in Psoriasis Knowledge Centre

Welcome to the IL-17A in Psoriasis Knowledge Centre of, the website for healthcare professionals. Within this site you can access a wealth of educational resources that discuss the role of the IL-17 pathway in the pathogenesis of psoriasis and the therapeutic potential of treatments directed towards IL-17A. You will find videos from leading experts, clinical presentations, content from international congresses, key publications and links to useful external resources. 

Latest content - Secukinumab Clinical Trial Data: Efficacy Slides
Latest content - Skin to live in website
Latest content - Interactive Publications


Secukinumab clinical trial data

Interactive Publications

Clinical Education
Each interactive publication includes the full text of a clinical paper about IL-17A inhibition in psoriasis. Within each interactive publication, information is organised into sections and tiered to allow the study to be reviewed quickly or explored in depth. Illustrated infographics highlight key data and concepts throughout. Current publications include: 'Secukinumab in Plaque Psoriasis - Results of two Phase 3 Trials', (Langley et al., 2014) and 'Secukinumab retreatment-as-needed versus fixed-interval maintenance regimen for moderate to severe plaque psoriasis: A randomized, double-blind, noninferiority trial (SCULPTURE)', (Mrowietz et al., 2015).

Featured website

,Skin to live in

Mechanistic Video